Replies to post #2635 on BioAdaptives Inc (BDPT)

[powerbattles]

FOUR REASONS WHY WE CAN ASSURE THE DILUTIVE TREND IS OVER.

1 - Referring to the current filings indicated nonconvertible notes issued in fiscal year 2023.

2 - A company registered with the Securities and Exchange Commission (SEC) is required to adhere to specific regulations and guidelines regarding the issuance of new securities, including notes. The SEC mandates that companies file appropriate documents, such as registration statements or disclosure statements, providing detailed information about the new securities being offered. These filings ensure transparency and protect investors by providing them with essential information to make informed decisions. Failure to comply with these regulations can result in legal consequences and penalties. $BDPT's registered with the Securities and Exchange Commission (SEC). Rest assured there will be no new note issue without proper disclosure statement.

3 - The company has a two-year timeframe to repay its debts, they wipeout the toxic debt now because the company want to ensure that the spin-off does not violate any debt covenants or negatively impact the rights and interests of the debt holders. In a spin-off, a company separates a portion of its business into a new independent entity, and this new entity can assume its own liabilities and debt obligations. Therefore, the company must take a necessary step to clean the book for the spin-off. No way they issue new note to jeopardized pending spin off.

4 - Since 2019, CEO Dr. Edward E. Jacobs took over control of the company, he has worked tirelessly to develop the products, and just recently, in April, they began their marketing campaign. announcing new board members, new products/patents/
licensing agreements, and other significant developments. The CEO and directors are genuinely focused on building the business. It's impressive these individuals have waived their compensation, demonstrating their commitment to retaining earnings and not simply seeking to issue toxic note to scam your money.

Item 11. Executive Compensation

We have employment agreements with our Chief Executive Officer, President and Chief Financial Officer, each of whom was to be compensated by stock grants accrued monthly based on current share prices or block grants during the period ended December 31, 2022. In consideration of the Company’s financial performance and lack of liquidity during this period, each of our officers waived compensation and we adjusted compensation accordingly.
The Company has no other executive compensation issues which would require the inclusion of other mandated table disclosures.
Director Compensation Our directors’ compensation is wholly derived from their employment agreement as set out above.

[powerbattles]

.0014 +21.74% let's goooo:)))